Daiichi Sankyo
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.
CEOHiroyuki Okuzawa
CEOHiroyuki Okuzawa
Employees19,765
Employees19,765
HeadquartersTokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded2005
Founded2005
Employees19,765
Employees19,765
DSNKY Key Statistics
Market cap34.05B
Market cap34.05B
Price-Earnings ratio16.34
Price-Earnings ratio16.34
Dividend yield2.16%
Dividend yield2.16%
Average volume303.28K
Average volume303.28K
High today$18.23
High today$18.23
Low today$17.97
Low today$17.97
Open price$18.18
Open price$18.18
Volume53.43K
Volume53.43K
52 Week high$28.21
52 Week high$28.21
52 Week low$17.44
52 Week low$17.44
DSNKY News
TipRanks 6d
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence StudyDaiichi Sankyo Company (DSKYF) announced an update on their ongoing clinical study. The study, officially titled “A Randomized, Single-center, Open-label, Sing...
Analyst ratings
94%
of 16 ratingsBuy
93.8%
Hold
6.3%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.